Literature DB >> 20177083

Identification, biopsy, and treatment of poorly understood premalignant, in situ, and indolent low-grade cancers: are we becoming victims of our own success?

Ferris M Hall1.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20177083     DOI: 10.1148/radiol.09092100

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  3 in total

1.  Diagnostic concordance among pathologists interpreting breast biopsy specimens.

Authors:  Joann G Elmore; Gary M Longton; Patricia A Carney; Berta M Geller; Tracy Onega; Anna N A Tosteson; Heidi D Nelson; Margaret S Pepe; Kimberly H Allison; Stuart J Schnitt; Frances P O'Malley; Donald L Weaver
Journal:  JAMA       Date:  2015-03-17       Impact factor: 56.272

2.  Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective.

Authors:  Joann G Elmore; Heidi D Nelson; Margaret S Pepe; Gary M Longton; Anna N A Tosteson; Berta Geller; Tracy Onega; Patricia A Carney; Sara L Jackson; Kimberly H Allison; Donald L Weaver
Journal:  Ann Intern Med       Date:  2016-03-22       Impact factor: 25.391

Review 3.  Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Douglas E Wood; Ella A Kazerooni; Scott L Baum; George A Eapen; David S Ettinger; Lifang Hou; David M Jackman; Donald Klippenstein; Rohit Kumar; Rudy P Lackner; Lorriana E Leard; Inga T Lennes; Ann N C Leung; Samir S Makani; Pierre P Massion; Peter Mazzone; Robert E Merritt; Bryan F Meyers; David E Midthun; Sudhakar Pipavath; Christie Pratt; Chakravarthy Reddy; Mary E Reid; Arnold J Rotter; Peter B Sachs; Matthew B Schabath; Mark L Schiebler; Betty C Tong; William D Travis; Benjamin Wei; Stephen C Yang; Kristina M Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2018-04       Impact factor: 11.908

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.